scholarly journals Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer

Medicine ◽  
2019 ◽  
Vol 98 (32) ◽  
pp. e16770 ◽  
Author(s):  
Koichi Sakaguchi ◽  
Hisako Ono ◽  
Katsuhiko Nakatsukasa ◽  
Takashi Ishikawa ◽  
Yoshie Hasegawa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Early Breast Cancer ◽  
Bone Mineral ◽  
Aromatase Inhibitors ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density

Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer

Maturitas ◽  
2010 ◽  
Vol 66 (3) ◽  
pp. 291-297 ◽  
Author(s):  
Xavier Nogues ◽  
Sonia Servitja ◽  
Maria Jesus Peña ◽  
Daniel Prieto-Alhambra ◽  
Rosa Nadal ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Postmenopausal Women ◽  
Early Breast Cancer ◽  
Bone Mineral ◽  
Aromatase Inhibitors ◽  
Mineral Density

scholarly journals Normal bone mineral density in cystic fibrosis

2001 ◽  
Vol 84 (4) ◽  
pp. 363-368 ◽  
Author(s):  
D S Hardin
Keyword(s):  
Bone Mineral Density ◽  
Cystic Fibrosis ◽  
Bone Mineral ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density

Five-year follow-up results of aerobic and circuit training on bone mineral density in early breast cancer patients

2020 ◽  
Vol 138 ◽  
pp. S81
Author(s):  
C. Blomqvist ◽  
L. Vehmanen ◽  
H. Sievänen ◽  
P. Kellokumpu-Lehtinen ◽  
R. Nikander ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Bone Mineral ◽  
Breast Cancer Patients ◽  
Mineral Density ◽  
Circuit Training

scholarly journals Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Maira L Mendonça ◽  
Francisco A Pereira ◽  
Marcello H Nogueira-Barbosa ◽  
Lucas M Monsignore ◽  
Sara R Teixeira ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density

scholarly journals Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors

2017 ◽  
Vol 13 (5) ◽  
pp. e505-e515 ◽  
Author(s):  
Jamie Stratton ◽  
Xin Hu ◽  
Pamela R. Soulos ◽  
Amy J. Davidoff ◽  
Lajos Pusztai ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Mineral Density ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Aromatase Inhibitors ◽  
Early Stage ◽  
Mineral Density ◽  
Dxa Scan ◽  
Bone Mineral Density Testing

Purpose: In postmenopausal women with breast cancer treated with aromatase inhibitors (AIs), most expert panels advise baseline bone mineral density testing with a dual-energy x-ray absorptiometry (DXA) scan repeated every 1 to 2 years. How often this recommendation is followed is unclear. Methods: We performed a retrospective analysis of women with stage I to III breast cancer who started AI therapy from January 1, 2008, to December 31, 2010, with follow-up through December 31, 2012, by using the SEER-Medicare database. Selection criteria included AI use for ≥ 6 months and no recent osteoporosis diagnosis or bisphosphonate use. We used multivariable logistic regression to investigate associations between patient characteristics and receipt of a baseline DXA scan. In patients who continued AI treatment, we assessed rates of follow-up scans. Results: In the sample of 2,409 patients (median age, 74 years), 51.0% received a baseline DXA scan. Demographic characteristics associated with the absence of a baseline DXA scan were older age (85 to 94 years v 67 to 69 years; odds ratio [OR], 0.62; 95% CI, 0.42 to 0.92) and black v white race (OR, 0.68; 95% CI, 0.47 to 0.97). Among patients who underwent a baseline DXA scan and continued AI for 3 years, 28.0% had a repeat DXA scan within 2 years and 65.9% within 3 years. In aggregate, of the 1,164 patients who continued with AI treatment for 3 years, only 34.5% had both a baseline and at least one DXA scan during the 3-year follow-up period. Conclusion: The majority of older Medicare beneficiaries with breast cancer treated with AIs do not undergo appropriate bone mineral density evaluation.

scholarly journals Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

2018 ◽  
Vol 30 (1) ◽  
pp. 1-4
Author(s):  
Mohammad Zabed Jillul Bari ◽  
Md Ismail Patwary ◽  
Md Delwar Hossain ◽  
Azizul Qadar Md Abdul Hye ◽  
Syed Mujibur Rahman
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Femoral Neck ◽  
Bone Mineral ◽  
Oral Steroid ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density ◽  
Male Patients ◽  
Prevalence Of Osteoporosis

Osteoporosis is one of the systemic features of COPD. Aims and objective is to determine the prevalence of osteoporosis in male COPD. In a cross-sectional study, we conducted dual-energy X-ray absorptiometry bone mineral density scans of the femoral neck and lumbar spine and collected data on smoking, duration of COPD, inhaled and oral corticosteroid treatment and staging by pulmonary function tests. We included 60 male patients with COPD, the mean age was 62.4 ± 8.1 years, smoking was 36.8 ± 17.2 smoking-pack year, duration of COPD was 5.4 ± 3.3 years, GOLD stage-III (56.7%) stage-IV (38.3%) and stage-II (5.0%), use of oral steroid (11.7%) inhaled steroid (63.3%) and none (25.0%). Normal bone mineral density was in 6 (10.0%), osteopenia in 24 (40.0%) and osteoporosis in 30 (50%) patients in femoral neck; whereas normal bone mineral density was in 4 (6.7%), osteopenia in 17 (28.3%) and osteoporosis in 39 (65.0%) patients in lumbar spine. Osteoporosis is highly prevalent in male COPD patients in both femoral neck and lumbar spine.Medicine Today 2018 Vol.30(1): 1-4

LOW OR NORMAL BONE MINERAL DENSITY IN FEMALE ELITE TRIATHLETES

2001 ◽  
Vol 33 (5) ◽  
pp. S227
Author(s):  
E W. Helge ◽  
M Waaddegaard ◽  
A Ottsen ◽  
I L. Kanstrup
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density
Sign in / Sign up

Export Citation Format

Share Document